|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751227B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
EP0863151A1
(en)
*
|
1997-02-12 |
1998-09-09 |
Akzo Nobel N.V. |
"Canine parvovirus dna vaccines"
|
|
CA2223029A1
(en)
|
1997-02-12 |
1998-08-12 |
Akzo Nobel Nv |
Canine parvovirus dna vaccines
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
EP1185662B1
(fr)
*
|
1999-06-10 |
2011-03-02 |
Merial |
Vaccins adn pour les chiens
|
|
FR2794648B1
(fr)
*
|
1999-06-10 |
2003-03-07 |
Merial Sas |
Vaccins adn pour animaux de compagnie et de sport
|
|
CA2431938A1
(en)
*
|
2001-02-15 |
2002-10-10 |
The Registrar, Indian Institute Of Science |
A novel vaccine formulation consisting of dna vaccine inactivated virus
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US7906311B2
(en)
|
2002-03-20 |
2011-03-15 |
Merial Limited |
Cotton rat lung cells for virus culture
|
|
CA2510189A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Thomas Gore |
Trivalent vaccine with maternal antibody transfer via the milk
|
|
EP2390352A1
(en)
|
2003-03-18 |
2011-11-30 |
Quantum Genetics Ireland Limited |
Systems and methods for improving protein and milk production of dairy herds
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
CA2529710A1
(en)
|
2003-06-20 |
2005-03-10 |
Protein Sciences Corporation |
Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
|
|
EP1689858B1
(en)
|
2003-11-13 |
2013-05-15 |
University Of Georgia Research Foundation, Inc. |
Methods of characterizing infectious bursal disease virus
|
|
EP1718770B1
(en)
|
2004-02-19 |
2011-05-25 |
The Governors of the University of Alberta |
Leptin promoter polymorphisms and uses thereof
|
|
WO2006115843A2
(en)
|
2005-04-25 |
2006-11-02 |
Merial Limited |
Nipah virus vaccines
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP3147296A1
(en)
|
2005-11-14 |
2017-03-29 |
Merial, Inc. |
Gene therapy for renal failure
|
|
US7767686B2
(en)
*
|
2006-03-03 |
2010-08-03 |
Covidien Ag |
Method of using adenosine receptor blockers during tissue ablation
|
|
WO2007115059A2
(en)
|
2006-03-29 |
2007-10-11 |
Merial Limited |
Vaccine against streptococci
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
US20080274137A1
(en)
*
|
2007-05-02 |
2008-11-06 |
Jean Christophe Francis Audonnet |
DNA plasmids having improved expression and stability
|
|
AU2007352618B2
(en)
|
2007-05-02 |
2013-07-18 |
Boehringer Ingelheim Animal Health USA Inc. |
DNA plasmids having improved expression and stability
|
|
CN102271704A
(zh)
|
2008-11-28 |
2011-12-07 |
梅里亚有限公司 |
重组禽流感疫苗及其用途
|
|
KR101715418B1
(ko)
|
2009-04-03 |
2017-03-10 |
메리얼 인코포레이티드 |
뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
|
|
KR20120101572A
(ko)
|
2009-12-28 |
2012-09-13 |
메리얼 리미티드 |
재조합 ｎｄｖ 항원 및 이의 용도
|
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
|
EP2944322B1
(en)
|
2010-03-12 |
2018-01-17 |
Merial, Inc |
Bluetongue virus recombinant vaccines and uses thereof
|
|
EP4014989A1
(en)
|
2010-08-31 |
2022-06-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Newcastle disease virus vectored herpesvirus vaccines
|
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
|
AU2012240240A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
WO2012138789A2
(en)
|
2011-04-04 |
2012-10-11 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
AP2013007180A0
(en)
|
2011-04-25 |
2013-10-31 |
Advanced Bioscience Lab Inc |
Truncated HIV envelope proteins (ENV), methods andcompositions related thereto
|
|
ES2764079T3
(es)
|
2011-05-27 |
2020-06-02 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacunas genéticas contra el virus Hendra y el virus Nipah
|
|
EP2714077B1
(en)
|
2011-06-01 |
2018-02-28 |
Merial, Inc. |
Needle-free administration of prrsv vaccines
|
|
CA2844927C
(en)
|
2011-08-12 |
2017-10-31 |
Merial Limited |
Vacuum-assisted preservation of biological products, in particular of vaccines
|
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
|
DK2814508T5
(da)
|
2012-02-14 |
2017-06-12 |
Merial Inc |
Rotavirus-underenhedsvacciner og fremgangsmåder til fremstilling og anvendelse deraf
|
|
EP3466443B1
(en)
|
2012-02-14 |
2020-12-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
RU2656187C2
(ru)
|
2012-06-13 |
2018-05-31 |
Мериал, Инк. |
Реассортантные btv и ahsv вакцины
|
|
US20140170180A1
(en)
|
2012-12-17 |
2014-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5a, methods of use and vaccine
|
|
US20140234354A1
(en)
|
2013-02-15 |
2014-08-21 |
Boehringer Ingelheim Vetmedica, Inc. |
Porcine parvovirus 5b, methods of use and vaccine
|
|
HK1216006A1
(zh)
|
2013-03-12 |
2016-10-07 |
Boehringer Ingelheim Animal Health USA Inc. |
反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
|
|
BR112016001192A2
(pt)
*
|
2013-08-21 |
2017-08-29 |
Curevac Ag |
Vacina contra a raiva
|
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
|
WO2016073410A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP4636401A2
(en)
|
2014-12-19 |
2025-10-22 |
The Broad Institute, Inc. |
Methods for profiling the t-cell-receptor repertoire
|
|
MX2017014700A
(es)
|
2015-05-20 |
2018-08-15 |
Broad Inst Inc |
Neoantigenos compartidos.
|
|
TW202241500A
(zh)
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
US9981033B2
(en)
|
2015-06-23 |
2018-05-29 |
Merial Inc. |
PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
|
|
MA42653A
(fr)
|
2015-08-20 |
2018-06-27 |
Merial Inc |
Vaccins recombinants contre le fcv et utilisations de ceux-ci
|
|
RS65084B1
(sr)
|
2015-09-29 |
2024-02-29 |
Boehringer Ingelheim Animal Health Usa Inc |
Vakcine čestica sličnih virusu (vlp) parvovirusa pasa (cpv) i njihova upotreba
|
|
CA3006078A1
(en)
|
2015-11-23 |
2017-06-01 |
Merial, Inc. |
Fmdv and e2 fusion proteins and uses thereof
|
|
RU2626605C2
(ru)
*
|
2015-11-25 |
2017-07-28 |
Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) |
Генетическая (рекомбинантная) ДНК-конструкция, содержащая кодон-оптимизированный ген гликопротеина (белка G) вируса бешенства с консенсусной аминокислотной последовательностью, которая составлена с учетом аминокислотных последовательностей белка G, выделяемого из штаммов вируса бешенства, циркулирующих на территории Российской Федерации
|
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
|
EP3446119A1
(en)
|
2016-04-18 |
2019-02-27 |
The Broad Institute Inc. |
Improved hla epitope prediction
|
|
WO2018140391A1
(en)
|
2017-01-24 |
2018-08-02 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
CN108704128B
(zh)
*
|
2018-05-15 |
2022-06-21 |
青岛农业大学 |
一种犬瘟热细小病毒二联亚单位疫苗
|
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
RU2707544C1
(ru)
*
|
2018-12-28 |
2019-11-27 |
Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) |
Генетическая конструкция на основе оптимизированного гена консенсусного гликопротеина вируса бешенства для профилактики бешенства
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
CN116735873B
(zh)
*
|
2023-08-09 |
2023-10-31 |
北京纳百生物科技有限公司 |
特异性结合犬细小病毒vp2蛋白的单克隆抗体在检测试剂中的应用
|